Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
TBPH

Market Cap: $881.6M

TI

Theravance Biopharma Inc

TBPH

NASDAQUSD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin89.40%

EBITDA Margin65.63%

EBIT Margin61.61%

Pre-tax Margin56.48%

Net Profit Margin51.58%

Earnings Yield6.12%

Valuation Multiples

Price / Book3.03

Price / Sales8.45

Price / Earnings15.99

PEG0.05

Forward PEG-0.45

EV / Sales6.71

EV / EBITDA10.23

EV / Operating Cash Flow13.51

EV / Free Cash Flow13.52

Price / Free Cash Flow17.01

Price / Operating Cash Flow16.96

Cash Flow & Capital

Free Cash Flow / Share$1

Operating Cash Flow / Share$1

Free Cash Flow Yield5.88%

Capex / Revenue0.01%

Capex / Operating Cash Flow0.02%

Capex / Depreciation0.00

Stock Compensation / Revenue18.74%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio13.54

Quick Ratio13.54

Cash Ratio7.14

Debt / Assets0.08

Debt / Capital0.12

Debt / Equity0.13

Long-Term Debt / Capital0.00

Debt / Market Cap0.00%

Net Debt / EBITDA-2.65

Solvency Ratio0.32

Financial Leverage1.62

Efficiency & Working Capital

Asset Turnover0.22

Fixed Asset Turnover3.85

Inventory Turnover0.00

Receivables Turnover5.12

Payables Turnover16.96

Days Sales Outstanding71.32

Days Inventory Outstanding0

Days Payables Outstanding21.52

Operating Cycle71.32

Cash Conversion Cycle49.8

Working Capital Turnover0.27

Returns & Quality

Return on Equity19.40%

Return on Assets11.45%

Return on Invested Capital0.95%

ROCE1.06%

Return on Tangible Assets11.45%

Operating Return on Assets0.99%

Income Quality0.96

Tax Burden0.91

Interest Burden0.92

Balance Sheet & Intrinsic Metrics

Enterprise Value$700.4M

Invested Capital$412.99M

Working Capital$385.9M

Tangible Asset Value$289.71M

Net Current Asset Value$236.6M

Graham Number$11.46

Graham Net-Net$4.31

Book Value / Share$5.61

Tangible Book Value / Share$5.61

Cash / Share$7.5

Financial Health Scores

Piotroski Score6

Altman Z-Score2.01

Revenue$104.31M

EBIT$64.26M

Market Cap$882.37M

Working Capital$385.9M

Retained Earnings$-870.46M

Total Assets$469.77M

Total Liabilities$180.07M